Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 3:14 pm Sale | 2025-03-31 | 13G | XORTX Therapeutics Inc. XRTX | ARMISTICE CAPITAL LLC | 178,031 4.990% | -168,776![]() (-48.67%) | Filing History |
| 2025-05-15 3:13 pm Sale | 2025-03-31 | 13G | Vincerx Pharma, Inc. VINC | ARMISTICE CAPITAL LLC | 274,908 4.990% | -4,200,213![]() (-93.86%) | Filing History |
| 2025-05-15 3:13 pm Purchase | 2025-03-31 | 13G | Travere Therapeutics, Inc. TVTX | ARMISTICE CAPITAL LLC | 8,872,000 9.990% | 1,514,000![]() (+20.58%) | Filing History |
| 2025-05-15 3:12 pm Purchase | 2025-03-31 | 13G | CERo Therapeutics Holdings, Inc. CERO | ARMISTICE CAPITAL LLC | 29,227 9.990% | 29,227![]() (New Position) | Filing History |
| 2025-05-15 3:12 pm Purchase | 2025-03-31 | 13G | Creative Medical Technology Holdings, Inc. CELZ | ARMISTICE CAPITAL LLC | 148,000 5.720% | 148,000![]() (New Position) | Filing History |
| 2025-05-15 3:11 pm Sale | 2025-03-31 | 13G | Kartoon Studios Inc. TOON | ARMISTICE CAPITAL LLC | 2,294,582 4.990% | -2,312,574![]() (-50.20%) | Filing History |
| 2025-05-15 3:10 pm Purchase | 2025-03-31 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | ARMISTICE CAPITAL LLC | 19,339 4.990% | 19,339![]() (New Position) | Filing History |
| 2025-05-15 3:10 pm Purchase | 2025-03-31 | 13G | Cibus, Inc. CBUS | ARMISTICE CAPITAL LLC | 1,948,000 5.970% | 1,948,000![]() (New Position) | Filing History |
| 2025-05-15 3:09 pm Purchase | 2025-03-31 | 13G | BIO-key International, Inc. BKYI | ARMISTICE CAPITAL LLC | 596,401 9.990% | 432,166![]() (+263.14%) | Filing History |
| 2025-05-15 3:09 pm Purchase | 2025-03-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA | ARMISTICE CAPITAL LLC | 285,037 9.990% | 285,037![]() (New Position) | Filing History |
| 2025-05-15 3:08 pm Purchase | 2025-03-31 | 13G | Bicycle Therapeutics plc BCYC | ARMISTICE CAPITAL LLC | 2,672,000 5.590% | 2,672,000![]() (New Position) | Filing History |
| 2025-05-15 3:08 pm Purchase | 2025-03-31 | 13G | Worksport Ltd. WKSP | ARMISTICE CAPITAL LLC | 492,232 9.990% | 492,232![]() (New Position) | Filing History |
| 2025-05-15 3:07 pm Purchase | 2025-03-31 | 13G | Brainstorm Cell Therapeutics Inc. BCLI | ARMISTICE CAPITAL LLC | 717,500 9.990% | 417,952![]() (+139.53%) | Filing History |
| 2025-05-15 3:07 pm Purchase | 2025-03-31 | 13G | STAAR Surgical Company STAA | ARMISTICE CAPITAL LLC | 3,000,000 6.080% | 3,000,000![]() (New Position) | Filing History |
| 2025-05-15 3:05 pm Purchase | 2025-03-31 | 13G | Alto Neuroscience, Inc. ANRO | ARMISTICE CAPITAL LLC | 1,600,000 5.910% | 1,600,000![]() (New Position) | Filing History |
| 2025-05-15 3:04 pm Purchase | 2025-03-31 | 13G | AngioDynamics, Inc. ANGO | ARMISTICE CAPITAL LLC | 2,094,000 5.160% | 2,094,000![]() (New Position) | Filing History |
| 2025-05-15 3:00 pm Purchase | 2025-03-31 | 13G | Aethlon Medical, Inc. AEMD | ARMISTICE CAPITAL LLC | 18,076 9.990% | 18,076![]() (New Position) | Filing History |
| 2025-02-14 5:52 pm Purchase | 2024-12-31 | 13G | Momentus Inc. MNTS | ARMISTICE CAPITAL LLC | 10,050 9.990% | 10,050![]() (New Position) | Filing History |
| 2025-02-14 5:52 pm Purchase | 2024-12-31 | 13G | MacroGenics, Inc. MGNX | ARMISTICE CAPITAL LLC | 6,276,000 9.990% | 6,276,000![]() (New Position) | Filing History |
| 2025-02-14 5:51 pm Purchase | 2024-12-31 | 13G | Moleculin Biotech, Inc. MBRX | ARMISTICE CAPITAL LLC | 13,591 9.990% | 13,591![]() (New Position) | Filing History |

